Structural characterization of interacting and aggregating cataract-associated crystallins
白内障相关晶状体蛋白相互作用和聚集的结构表征
基本信息
- 批准号:10395057
- 负责人:
- 金额:$ 5.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-30 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAgingBehaviorBiochemicalBlindnessCataractCellsChemicalsCrystalline LensCrystallinsCrystallizationDataDegenerative DisorderDiseaseDisease ProgressionElectron MicroscopyGene MutationHumanIndividualLens OpacitiesLightLiquid substanceMapsMethodologyMethodsModificationNMR SpectroscopyNuclear Magnetic ResonanceOperative Surgical ProceduresPhasePhysiologicalPopulationPost-Translational Protein ProcessingProcessProteinsReportingResearchRoentgen RaysScienceStructureStructure-Activity RelationshipSurfaceSurgical complicationVariantVisual impairmentage relatedagedbiophysical analysiscongenital cataractexperimental studyinsightlenslens transparencymutantnovelnovel therapeutic interventionnovel therapeuticsprotein aggregationprotein protein interactionsolid state nuclear magnetic resonance
项目摘要
Project Summary
Cataracts are the leading cause of blindness in the world, with approximately 22 million cases per year. The
disease is caused by protein aggregation in the eye lens, involving its major constituents, the crystallins.
Currently, the only available treatment is surgery, widely used in the developed world. However, access to
surgery is not available to a significant fraction of the world population, and, as with any surgery, complications
may ensue. Therefore, it is important to provide a structural understanding of cataract formation, if novel
therapeutic approaches are to be developed for delaying the onset or slowing the progression of cataracts. While
the congenital form of the disease has been mapped to crystallin gene mutations, the age-related degenerative
disease is believed to involve chemically-modified crystallin proteins. Previously, we investigated the dynamics,
structure and folding of human gD-crystallin mutants that are associated with congenital cataracts. We solved
NMR and X-ray crystal structures of several variants and analyzed their dynamic behavior by solution NMR
spectroscopy. Our aim now is to elucidate the interactions between different crystallins, under physiologically-
relevant high concentrations. We will investigate proteins with modifications that mimic aging and using
congenital cataract-associated mutants. We hypothesize that surface changes that impact the liquid phase
behavior of the crystallin and/or generate aberrant protein-protein interactions contribute to aggregation.
Our studies will not only provide insight into the process of cataract formation but also will shed light on
fundamental questions in protein science. Although biochemical and biophysical studies have provided a detailed
picture of individual crystallin structures and stability, extensive studies are needed to assess the interplay
between different crystallin proteins and, thereby, provide critical data on crystallin structure/function
relationships. For example, the interactions that permit high protein concentrations in lens cells and questions
about which, why, and how certain crystallins interact without aggregation in the normal lens require direct
experimental studies to gain new insights. In addition, several post-translational modifications have been
reported to occur upon lens aging, impacting lens transparency. Whether and how such "aged" crystallins
contribute to protein stability and aggregation is unknown. The proposed research will address these outstanding
issues through biophysical analyses of wild-type, disease-associated, and chemically-modified, “aged”, crystallin
variants. Structural studies by solution and solid-state nuclear magnetic resonance (NMR) spectroscopy, small
angle x-ray scattering (SAXS), and electron microscopy methods will be used to directly investigate different
crystallin mixtures to obtain novel insights into the behavior of normal assemblies involving lens-opacity
associated proteins. Structural details of such assemblies cannot be obtained by any other methodologies.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANGELA M. GRONENBORN其他文献
ANGELA M. GRONENBORN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANGELA M. GRONENBORN', 18)}}的其他基金
Molecular, Cellular and Behavioral Impact of the R203W PACS1 Syndrome Mutation
R203W PACS1 综合征突变的分子、细胞和行为影响
- 批准号:
10440654 - 财政年份:2022
- 资助金额:
$ 5.85万 - 项目类别:
Pittsburgh Center for HIV Protein Interactions (PCHPI)
匹兹堡 HIV 蛋白质相互作用中心 (PCHPI)
- 批准号:
10506945 - 财政年份:2022
- 资助金额:
$ 5.85万 - 项目类别:
Pittsburgh Center for HIV Protein Interactions (PCHPI)
匹兹堡 HIV 蛋白质相互作用中心 (PCHPI)
- 批准号:
10653242 - 财政年份:2022
- 资助金额:
$ 5.85万 - 项目类别:
Molecular, Cellular and Behavioral Impact of the R203W PACS1 Syndrome Mutation
R203W PACS1 综合征突变的分子、细胞和行为影响
- 批准号:
10612914 - 财政年份:2022
- 资助金额:
$ 5.85万 - 项目类别:
Structural characterization of interacting and aggregating cataract-associated crystallins
白内障相关晶状体蛋白相互作用和聚集的结构表征
- 批准号:
10463640 - 财政年份:2019
- 资助金额:
$ 5.85万 - 项目类别:
相似海外基金
RUI: CAS-MNP: Molecular Behavior at Colloidal/Aqueous Interfaces of Heterogeneous Nano- and Micro-Plastics - Binding Interactions and Effect of Aging
RUI:CAS-MNP:异质纳米和微米塑料胶体/水界面的分子行为 - 结合相互作用和老化效应
- 批准号:
2304814 - 财政年份:2023
- 资助金额:
$ 5.85万 - 项目类别:
Standard Grant
Exploring the potential of systemic contribution to altered pain behavior in aging mice
探索系统性改变衰老小鼠疼痛行为的潜力
- 批准号:
478176 - 财政年份:2023
- 资助金额:
$ 5.85万 - 项目类别:
Operating Grants
Reducing suicide risk among aging caregivers of persons with AD/ADRD: Adapting, implementing, and evaluating Dialectical Behavior Therapy skills training interventions.
降低 AD/ADRD 患者老年护理人员的自杀风险:调整、实施和评估辩证行为治疗技能培训干预措施。
- 批准号:
10730708 - 财政年份:2023
- 资助金额:
$ 5.85万 - 项目类别:
Inferring multi-scale dynamics underlying behavior in aging C. elegans
推断衰老线虫行为背后的多尺度动力学
- 批准号:
10638631 - 财政年份:2023
- 资助金额:
$ 5.85万 - 项目类别:
Exploring the potential of systemic contribution to altered pain behavior in aging mice
探索系统性改变衰老小鼠疼痛行为的潜力
- 批准号:
477269 - 财政年份:2022
- 资助金额:
$ 5.85万 - 项目类别:
Operating Grants
From Molecules to Behavior: Understanding How Aging Impacts Entorhinal-based Navigation
从分子到行为:了解衰老如何影响基于内嗅的导航
- 批准号:
10786033 - 财政年份:2022
- 资助金额:
$ 5.85万 - 项目类别:
From Molecules to Behavior: Understanding How Aging Impacts Entorhinal-based Navigation
从分子到行为:了解衰老如何影响基于内嗅的导航
- 批准号:
10535298 - 财政年份:2022
- 资助金额:
$ 5.85万 - 项目类别:
Longitudinal Characterization of Nutritional Behavior Using Unobtrusive Digital Technology in Aging, Alzheimer's and Related Disorders
使用不显眼的数字技术对衰老、阿尔茨海默病和相关疾病的营养行为进行纵向表征
- 批准号:
10369909 - 财政年份:2022
- 资助金额:
$ 5.85万 - 项目类别:
Google Cloud Pipeline for mouse behavior and frailty assessment for the aging research community
Google Cloud Pipeline 用于衰老研究社区的小鼠行为和虚弱评估
- 批准号:
10827671 - 财政年份:2022
- 资助金额:
$ 5.85万 - 项目类别:
Contextual and Health Behavior Effects on Epigenetic Aging Among African Americans
背景和健康行为对非裔美国人表观遗传衰老的影响
- 批准号:
10249106 - 财政年份:2018
- 资助金额:
$ 5.85万 - 项目类别:














{{item.name}}会员




